This act expands Medicare options for those aged 50-64, introduces a direct supplemental insurance option, empowers drug price negotiation, stabilizes the individual insurance market, and removes the income cap for premium tax credits.
Raja Krishnamoorthi
Representative
IL-8
The Medicare Expansion and Lowering Costs Now Act aims to enhance healthcare access and affordability through several key provisions. It establishes a Medicare buy-in option for individuals aged 50 to 64, creates a new direct supplemental insurance option for Original Medicare beneficiaries, and grants the Secretary authority to negotiate lower Part D drug prices. Additionally, the bill stabilizes the individual insurance market by establishing a reinsurance fund and removes the income cap for premium tax credit eligibility.
Alright, let's talk about something that could genuinely shift how healthcare works for a huge chunk of folks: the "Medicare Expansion and Lowering Costs Now Act." This isn't just some tweak; it's a multi-pronged approach to tackle everything from early Medicare access to prescription drug costs and even how you pay for insurance through the Affordable Care Act (ACA).
First up, this bill throws a lifeline to those aged 50 to 64 who aren't yet Medicare eligible. Think about it: you're not quite 65, maybe you've lost your job, or your employer plan is just too expensive. This bill says, "Hey, you can buy into Medicare." Specifically, Section 3 creates a Medicare buy-in option, letting individuals in this age bracket get the same benefits as someone with Parts A, B, and D. This means access to Medicare Advantage plans and even a Medicare Beneficiary Ombudsman. Enrollment periods will sync up with the ACA Exchange, making it easier to navigate. Premiums will be calculated annually by the Secretary of Health and Human Services, adjusted for geography, and can even vary by age to encourage enrollment. Plus, there's financial assistance, similar to what you'd get on an ACA Exchange, to help with those premium costs. This is a big deal for people who often find themselves in a coverage gap, but it's worth noting that states can't buy their Medicaid beneficiaries into this program, which could leave some vulnerable people out in the cold.
For those already on Original Medicare (Parts A and B), Section 4 introduces a new "Medicare direct supplemental insurance option." This is designed to help cover those pesky out-of-pocket costs like deductibles and copayments after you hit a $100 annual deductible. Enrollment starts with an initial period in late 2027, with coverage beginning January 1, 2028. Here's a key point: no pre-existing condition limits or underwriting restrictions apply, which is huge. The monthly premium will be community-rated—meaning it's the same for everyone—but watch out for a late enrollment penalty, which can add up to 100% to your premium if you drag your feet. So, if you're on Original Medicare, this could be a solid option to rein in those unpredictable costs.
This is where things get really interesting for your wallet. Section 5 gives the Secretary of Health and Human Services direct authority to negotiate lower drug prices with pharmaceutical manufacturers for Medicare Part D beneficiaries. This isn't just a suggestion; it's a mandate. While the Secretary can't dictate a specific formulary (the list of covered drugs), this move aims to bring down the cost of medications for millions of seniors. Starting in 2029, we should see the impact of these negotiations. This is a direct shot at making prescription drugs more affordable, which is a constant headache for many households.
Beyond Medicare, the bill also looks at the broader health insurance landscape. Section 6 creates an "Individual Market Reinsurance Fund" to help stabilize the individual health insurance market starting in 2029. This fund will make payments to health insurance issuers for high-cost individuals, covering 80% of claims between certain thresholds (e.g., $50,000 and $450,000 for 2026-2028). The idea is to take some of the financial risk off insurers, which could lead to more stable premiums and more choices for consumers. Plus, Section 7 reauthorizes the ACA's risk corridors program, extending it through 2031, another move aimed at market stability.
Finally, and this is a big one for many, Section 10 makes a significant change to the ACA's premium tax credits. It removes the income cap for eligibility and restructures how the credit is calculated. Currently, if your household income is over 400% of the federal poverty level, you're out of luck. This bill says that cap is gone. Instead, there will be a new sliding scale, meaning more people will qualify for help with their health insurance premiums. This applies to taxable years beginning after December 31, 2026, and could make a huge difference in monthly budgets for middle-income families who currently pay full price for their ACA plans.
In essence, this bill is trying to make healthcare more accessible and affordable on multiple fronts, from expanding Medicare options to tackling drug costs and making ACA plans more attainable. It's a comprehensive package that could touch a lot of lives, particularly those navigating the often-tricky years before full Medicare eligibility and those struggling with the cost of prescriptions.